Related Experiment Video
Updated: Dec 11, 2025

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Long non-coding RNA regulation of TRAIL in breast cancer: A tangle of non-coding threads
Zeeshan Javed1, Khushbukhat Khan2, Muhammad Zaheer Iqbal3
1Office for Research Innovation and Commercialization, Lahore Garrison University, Lahore, Punjab 54792, Pakistan.
Abstract:
Breast cancer is a complex disease posing a serious threat to the female population worldwide. A complex molecular landscape and tumor heterogeneity render breast cancer cells resistant to drugs and able to promote metastasis and invasiveness. Despite the recent advancements in diagnostics and drug discovery, finding an effective cure for breast cancer is still a major challenge. Positive and negative regulation of apoptosis has been a subject of extensive study over the years. Numerous studies have shed light on the mechanisms that impede the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling cascade. Long non-coding RNAs (lncRNAs) have been implicated in the orchestration, development, proliferation, differentiation and metastasis of breast cancer. However, the roles of lncRNAs in fine-tuning apoptosis regulating machinery in breast cancer remain to be elucidated. The present review illuminates the roles of these molecules in the regulation of breast cancer and the interplay between lncRNA and TRAIL in breast cancer. The present review also attempts to reveal their role in the regulation of apoptosis in breast cancer appears a promising approach for the development of new diagnostic and therapeutic regimens.
Insights
Long non-coding RNAs (lncRNAs) regulate breast cancer progression and drug resistance. This review explores lncRNA interplay with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling, offering new therapeutic strategies for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer presents a significant global health challenge due to its complex molecular characteristics and heterogeneity.
- Tumor heterogeneity contributes to drug resistance, metastasis, and invasiveness in breast cancer.
- Despite advancements, effective breast cancer cures remain elusive, highlighting the need for novel therapeutic targets.
Purpose of the Study:
- To elucidate the role of long non-coding RNAs (lncRNAs) in regulating breast cancer.
- To investigate the interplay between lncRNAs and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling in breast cancer.
- To explore the potential of lncRNA-TRAIL interactions as a basis for new breast cancer diagnostics and therapeutics.
Main Methods:
- Literature review focusing on lncRNAs in breast cancer.
- Analysis of existing studies on apoptosis regulation in breast cancer.
- Examination of the mechanisms underlying TRAIL signaling pathway in breast cancer.
Main Results:
- lncRNAs are implicated in breast cancer development, proliferation, and metastasis.
- Dysregulation of apoptosis is a key factor in breast cancer progression and treatment resistance.
- lncRNAs modulate the apoptosis-regulating machinery, including the TRAIL signaling pathway.
Conclusions:
- lncRNAs play a critical role in breast cancer pathogenesis and progression.
- The interaction between lncRNAs and TRAIL signaling represents a promising avenue for therapeutic intervention.
- Targeting lncRNA-mediated apoptosis regulation could lead to novel diagnostic and therapeutic strategies for breast cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression at Multiple Steps
